Silicon compounds and their use

Details for Australian Patent Application No. 2004255912 (hide)

Owner Paradigm Therapeutics Ltd.

Inventors Showell, Graham Andrew; Miller, David John; Walsh, Louise Marie; Ruprah, Parminder Kaur

Agent Davies Collison Cave

Pub. Number AU-B-2004255912

PCT Pub. Number WO2005/005442

Priority 0410831.2 14.05.04 GB; 0316204.7 10.07.03 GB

Filing date 18 June 2004

Wipo publication date 20 January 2005

Acceptance publication date 1 May 2008

International Classifications

A61P 5/00 (2006.01) Drugs for disorders of the endocrine system

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

C07F 7/08 (2006.01) Compounds containing elements of the 4th Group of the Periodic System

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/005442 Priority application(s): WO2005/005442

1 May 2008 Application Accepted

  Published as AU-B-2004255912

28 August 2008 Standard Patent Sealed

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004255913-Organosilicon compounds and their use

2004255905-Preparation of 1,3-diphenylprop-2-en-1-one derivatives